Ani Pharmaceuticals Inc (ANIP)
Cost of Revenue
$100.16M
Quarterly · Period ending: · USD
ANIP Cost of Revenue
Latest reported$100.16Mperiod ending
Latest reported$100.16Mperiod ending
ANIP Quarterly Cost of Revenue ($0.00 → $100.16M)
Quarterly cost of revenue
High-resolution chart · PNG
ANIP cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 100,158,000 | |
| 114,501,000 | |
| 9,500,000 | |
| 116,021,000 | |
| 74,615,000 | |
| 73,037,000 | |
| 80,280,000 | |
| 63,075,000 | |
| 57,698,000 | |
| 49,157,000 | |
| 53,420,000 | |
| 48,101,000 | |
| 42,284,000 | |
| 37,708,000 | |
| 36,326,000 | |
| 32,894,000 | |
| 35,294,000 | |
| 34,271,000 | |
| 33,898,000 | |
| 24,413,000 | |
| 22,314,000 | |
| 19,985,000 | |
| 24,540,000 | |
| 20,118,000 | |
| 20,695,000 | |
| 21,804,000 | |
| 17,795,000 | |
| 15,002,000 | |
| 15,632,000 | |
| 14,725,000 | |
| 20,133,000 | |
| 15,605,000 | |
| 16,593,000 | |
| 20,693,000 | |
| 20,446,000 | |
| 21,078,000 | |
| 21,122,000 | |
| 16,386,000 | |
| 16,906,000 | |
| 16,669,000 | |
| 11,795,000 | |
| 3,410,000 | |
| 3,540,000 | |
| 3,260,000 | |
| 3,141,000 | |
| 2,751,000 | |
| 3,673,000 | |
| 3,061,000 | |
| 2,117,000 | |
| 2,622,000 | |
| 2,684,000 | |
| 2,629,119 | |
| 2,098,540 | |
| 2,408,000 | |
| 2,874,623 | |
| 2,321,773 | |
| 0 | |
| 0 | |
| 50,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |